Glucagon-like peptide-1-(7-36) amide and peptide yy mediate intraduodenal fat-induced inhibition of acid secretion in dogs

Endocrinology

Volumn 139, Issue 1, 1998, Pages 189-194

  Fung, Leslie C ^a   Chisholm, Connie ^a   Greenberg, Gordon R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011476002     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.139.1.5700     Document Type: Article

References (44)

1. Feng TP, Hou HC, Lim RKS1929 On the mechanism of the inhibition of gastric secretion by fat. Chin J Physiol 3:371-380
2. Kosaka T, Lim RKS 1930 Demonstration of the hormonal agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 27:890-891
3. Lloyd KCK, Maxwell V, Kovacs TOG, Miller J, Walsh JH 1992 Cholecysto-kinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology 102:131-138
4. Fung L, Pokol-Daniel S, Greenberg GR 1994 Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin in dogs. Endocrinology 134:2376-2382
5. Soil AH, Amirian DA, Thomas LP, Reedy JD, Elashoff JD 1984 Gastrin receptors on isolated canine parietal cells. J Clin Invest 73:1434-1447
6. McFadden DW, Rudnicki M, Kuvshinoff B, Fischer JE 1992 Postprandial peptide YY release is mediated by cholecystokinin. Surg Gynecol Obstet 175:145-150
7. Pappas TN, Debas HT, Goto Y, Taylor IL 1985 Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 248:G118-G123
8. Bottcher G, Sjolund K, Ekblad E, Hakanson R, Schwartz TW, Sundler F1984 Coexistance of peptide YY and glicentin immunoreactivity in the endocrine cells of the gut. Regul Pept 8:261-266
9. Schjoldager BGT, Mortensen PE, Christiansen J, Orskov C, Holst JJ 1989 GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 35:703-708
10. Wettergren A, Schjoldager BGT, Mortensen PE, Myhre J, Christiansen J, Holst JJ 1993 Truncated GLP-1 (proglucagon 78-107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665-673
11. Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ 1994 Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29:501-505
12. Lin CW, Miller TR1992 Both CCK-A and CCK-B/gastrin receptors are present on rabbit vagus nerve. Am J Physiol 263:R591-R595
13. Corp ES, McQuade J, Moran TH, Smith GP 1993 Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res 623:161-166
14. Eissele R, Sandfort-Bothe E, Goke B, Eng J, Arnold R, Koop H1994 Rat gastric somatostatin and gastrin release; interactions of exendin-4 and truncated glu-cagon-like peptide-1 (GLP-1) amide. Life Sci 55:629-634
15. Eissele R, Koop H, Arnold R1990 Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in rat. Scand J Gastroenterol 25:449-454
16. Brubaker PL, Efendic S, Greenberg GR 1997 Truncated and full-length glu-cagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release. Endocrine 6:91-95
17. Seal A, Yamada T, Debas H, Hollinshead J, Osadchey B, Aponte G, Walsh J 1982 Somatostatin-14 and -28: clearance and potency on gastric function in dogs. Am J Physiol 243:G97-G102
18. Fung LC, Greenberg GR 1997 Characterization of somatostatin receptor sub-types mediating inhibition of nutrient-stimulated gastric acid and gastrin in dogs. Regul Pept 68:197-203
19. Greenberg GR, Wolman SL, Christofides ND, Bloom SR, Jeejeebhoy KN 1981 Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 80:988-999
20. Hall KE, Greenberg GR, El-Sharkaway TY, Diamant NE 1983 Vagal control of migrating motor complex-related peaks in canine plasma motilin, pancreatic polypeptide, and gastrin. Can J Physiol Pharmacol 61:1289-1298
21. Brubaker PL, Drucker DJ, Asa A, Greenberg GR 1991 Synthesis and secretion of peptide YY by fetal rat intestinal cells in culture. Endocrinology 129:3351-3358
22. Greenberg GR 1993 Differential neural regulation of circulating somatosta-tin-14 and-28 in conscious dogs. Am J Physiol 264:G902-G909
23. Roberge JN, Brubaker PL 1993 Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240
24. Fu-Cheng X, Anini Y, Chariot J, Voisin T, Galmiche J-P, Roze C 1995 Peptide YY release after intraduodenal intra ileal and intracolonic administration of nutrients in rats. Pflugers Arch Eur J Physiol 431:66-75
25. Andreasen JJ, Orskov C, Holst JJ 1994 Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion 55:221-228
26. Greeley GH, Jeng YJ, Gomez G, Hashimoto T, Hill FLC, Kern K, Kurosky T, Chuo HF, Thompson JC1989 Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 124:1438-1443
27. Fieseler P, Bridenbaugh S, Nustede R, Martell J, Orskov C, Holst JJ, Nauck MA1995 Physiology augmentation of amino acid-induced insulin secretion by GIP and GLP-1 but not by CCK-8. Am J Physiol 268:E949-E955
28. Dumoulin V, Dakka T, Plaisancie P, Chayvialle J A, Cuber JC 1995 Regulation of glucagon-like peptide-l-(7-36) amide, peptide YY and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Endocrinology 136:5182-5188
29. Holzer H, Turkelson CM, Solomon TE, Raybould HE 1994 Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathways in rats. Am J Physiol 267:G625-G629
30. Schwartz GJ, Tougas G, Moran TH 1995 Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats. Peptides 16:707-711
31. Boulant J, Fioramonti J, Dapoigny M, Bommelaer G, Bueno L 1994 Chole-cystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. Gastroenterology 107:1059-1066
32. Li Y, Owang C 1993 Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 92:418-424
33. Pappas TN, Debas HT, Goto Y, Taylor IL 1986 Enterogastrone like effect of peptide YY is vagally mediated in the dog. J Clin Invest 77:49-53
34. Guo YS, Fujimura M, Lluis F, Tsong Y, Greeley GH, Thompson JC 1987 Inhibitory action of peptide YY on gastric acid secretion. Am J Physiol 253:G298-G302
35. Wettergren A, Maina P, Boesby S, Holst JJ 1997 Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand J Gastroenterol 32:552-555
36. Chey WY, Kim MS, Lee KY, Chang TM 1981 Secretin is an enterogastrone in the dog. Am J Physiol 240:G239-G244
37. Wen J, Phillips SF, Sarr MG, Kost LJ, Holst JJ 1995 PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 269:G945-G952
38. SchmidtlerJ, Schepp W, Janczewska I, Weigert N, Furlinger C, Schusdiziarra V, Classen M 1991 GLP-l-(7-36) amide, -(1-37), and -(1-36) amide: potent cAMP-dependent stimuli of rat parietal cell function. Am J Physiol 260:G940-G950
39. Leth R, Lundell, Olbe L 1991 Effects of some gastrointestinal peptides on isolated human and rabbit gastric glands. Scand J Gastroenterol 26:89-96
40. Orskov C, Holst JJ, Nielson OV 1988 Effect of truncated glucagon-like pep-tide-1 (proglucagon 78-107 amide) on endocrine secretion from pig pancreas, antrum and stomach. Endocrinology 123:2009-2013
41. Wiley JW, Lu Y, Owang C 1991 Mechanism of action of peptide YY to inhibit gastric motility. Gastroenterology 100:865-872
42. Zeng N, Walsh J, Kang T, Wu V, Sachs G 1997 Peptide YY inhibition of rat gastric enterochromoaffin-like cell function. Gastroenterology 112:127-135
43. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B 1993 Exendin-4 is a high potency agonist and truncated exendin (9-39) amide an antagonist at the glucagon-like peptide l-(7-36)-amide receptor of insulin secreting cells. J Biol Chem 268:19650-19655
44. Kolligs F, Fehmann HC, Goke R, Goke B 1995 Reduction of the incretin effect in rats by the glucagon-like peptide-1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19